Innovation & Tech
AstraZeneca Oncology Data Signals Pipeline Resilience Despite Breast Cancer Trial Miss
AstraZeneca reported a Phase 3 setback for its breast cancer drug Etcamah, but strong long-term Tagrisso survival data and positive Enhertu lung cancer results highlighted the breadth of its oncology pipeline.